论文部分内容阅读
硝苯吡啶(Nifedipine)系二氢吡啶衍化物,其临床研究始于1972年。研究表明,这是一种冠状动脉扩张药,能减少冠状小动脉阻力而增加冠状血流量,并具有阻滞钙离子通过细胞膜进入心肌细胞的作用。硝苯吡啶对于稳定性和变异型心绞痛的疗
Nifedipine (Nifedipine) Department of dihydropyridine derivatives, the clinical study began in 1972. Studies have shown that this is a coronary dilating drug that reduces coronary artery resistance and increases coronary blood flow and blocks the entry of calcium ions into the cardiomyocytes through the cell membrane. Nifedipine for stability and variant angina pectoris